VHL about to POP!!, page-44

Good luck with your investing, Roujuzi.

The reasons I'm in VHL are:

A good suite of clinical trials with potential, and are partly paid for by third parties.
A low market cap at ~$8 mill. I'm looking for a rerate to at least $15 mill and then higher on positive trial results.
A CEO with a proven track record.
Possible pharma interest in some of their clinical trials.

Have a look at the press report in today's Herald Sun for a bit more info.

Good luck.